This motivated us to develop a fusion protein that includes murine IgG1 Fc linked to CXCL10 (CXCL10-Ig or CXCL10-Fc) for cancer therapy, and CXCL11 fused to the same construct for therapy of autoimmunity (CXCL11-Ig or CXCL11-Fc) [190]. The gene discussed is CXCL11; the disease is Autoimmunity.